To Top
  1. Strengthening the Outsource Service Offering through Integration

    Controlling costs and increasing efficiencies are two fundamental drivers for outsourcing of pharmaceutical manufacturing, explains Luigi Trussardo, CEO of Olon Ricerca Bioscience.

  2. How to Tell If You’re Using a Quality Hard Capsule

    Bahi Mahesan, Regulatory Affairs and Quality Manager for CapsCanada, explains the benefits of using a high-quality supplier for hard-shell capsules.

  3. Five Tips to Ensure Faster Equipment Procurement and Installation
    Used equipment is readily available, cuts lead time for delivery and install, and allows faster product launch, says Jim Coyne, Business Development/Sales at Federal Equipment Company.
  4. Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing

    Ariana Nagel, Director of Product Development, R&D and and Matthew Ferrell, Director of Analytical Development at UPM Pharmaceuticals explain the benefits and challenges of peptide therapies.

  5. Addressing the Challenges and Opportunities Presented by Advanced Therapies

    Phacilitate Leaders World, World Stem Cell Summit (WSCS), Cell & Gene Therapy World, Immuno-Oncology Frontiers World and Cord Blood & Perinatal Stem Cells Summit conferences to be held at the Hyatt Regency Miami, January 22-25, 2019. 

  6. From Proof of Concept to Commercialization

    Mark Bamforth, CEO and Richard Snyder, CSO, explain how Brammer Bio is investing to support the commercial development of gene and cell therapies.

  7. FDA Approves First Inhaler with Built-in Sensors

    Teva Pharmaceutical Industries integrated digital rescue inhaler connects to a smartphone app.


  8. Allergan Establishes R&D Group in Massachusetts
    Kendall Square site will allow Allergan to connect with venture capital groups and startups in Cambridge.
  9. Longeveron Receives Prestigious NIH  Small Business Innovation Research Grant

    Grant will be applied to Longeveron’s Aging Frailty stem cell research.

  10. Experimental Treatment Approach Shows Potential against Staphylococcus aureus

    A new class of engineered proteins may counter infection caused by Staphylococcus aureus – a bacterial species considered one of the largest global health threats.

  11. Dedicated CDMO Services Meet Customer Needs in the Dynamic Biopharma Sector

    Federico Pollano, Senior Vice President Business Development, Rentschler Biopharma SE, outlines the advantages of a dedicated CDMO.

  12. Hard-Shell Capsule Solutions for Sensitive Compounds: A Focus on Probiotics

    Eli Elias, Director of Business Development for CapsCanada explains why hard-shell capsules designed to degrade under specific conditions are a better option for probiotics.

  13. Meeting Biopharma Contract Manufacturing Needs with a Flexible Global Network

    Gustavo Mahler, President & CEO of AGC Biologics discusses the increasing need for CDMO support to provide with advanced capabilities and technology platforms across scales and geographies. 

    President & CEOAGC Biologics
  14. Fully Supporting Customer Needs for Biologics Development and Manufacturing

    James Park, Senior Vice President and Global Head, Business Development Center for Samsung BioLogics discusses the construction of three state-of-the-art production facilities in the last seven years.

  15. Remembering the Details: Partnering with an Equipment Supplier During a Merger or Acquisition

    Justin Kadis, Business Development for Federal Equipment Company explains how to deal with asset management issues following a merger or acquisition.

  16. Biotech Company Stealth BioTherapeutics Files for IPO

    Stealth BioTherapeutics hopes to raise $86 million in a Nasdaq IPO to fund development of mitochondrial dysfunction drug.

  17. Antengene Benefits from Second-Round Financing
    The Chinese biotech raises $120 million.
  18. Newly Discovered Phagocyte Plays Role in Autoimmune Disease

    Hemophagocytes, a newly identified population of phagocytes, may have a direct impact on patients with a variety of autoimmune diseases.

  19. China Cancer Drugs Market 2018-2024: Rising Demand of Targeted Drug Therapy and the Patent Expiration of Key Cancer Drugs

    The Chinese cancer drug market is projected to reach US$ 30 Billion by the year 2024. 

  20. Establishing Specialized CDMO Capabilities for the Production of Advanced Therapies
    Oliver Technow, President of BioVectra, explains the necessity of forward-thinking CDMOs.
Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
Drug Development

Addressing the Challenges and Opportunities Presented by Advanced Therapies

Jan 15, 2019 5:09:05 PM PAO-M01-19-NI_CL-001
Drug Development

Researchers Identify Potential Approach for Treating the Toughest Breast Cancer

Jan 9, 2019 4:13:58 PM PAO-M01-19-NI-013

Sanofi and Regeneron Immuno-oncology Collaboration Ending

Jan 9, 2019 2:43:05 PM PAO-M01-19-NI-012

Swiss AI Firm Raises Funds for Entry into U.S.

Jan 9, 2019 2:39:22 PM PAO-M01-19-NI-011

Allergan Establishes R&D Group in Massachusetts

Jan 9, 2019 2:32:28 PM PAO-M01-19-NI-010

FDA Approves First Inhaler with Built-in Sensors

Jan 9, 2019 2:27:00 PM PAO-M01-19-NI-009

Antengene Benefits from Second-Round Financing

Jan 8, 2019 11:10:49 AM PAO-M01-19-NI-008

Biotech Company Stealth BioTherapeutics Files for IPO

Jan 8, 2019 11:05:35 AM PAO-M01-19-NI-007
Clinical Trials

Initial Positive Results Lead to Expanded Cancer Trial

Jan 8, 2019 11:00:42 AM PAO-M01-19-NI-006
Cell and Gene Therapy

New Assays for Detecting Genomic Mutations Launched by Contextual Genomics

Jan 8, 2019 10:58:34 AM PAO-M01-19-NI-005

Vedanta Increases Investment

Jan 8, 2019 10:55:28 AM PAO-M01-19-NI-004
Drug Pricing

Drug Companies Raise Prices to Start New Year

Jan 8, 2019 10:51:10 AM PAO-M01-19-NI-003
FDA Approval

FDA Approves Parkinson’s Drug

Jan 8, 2019 10:45:34 AM PAO-M01-19-NI-002

Nice Insight Overview

The Evolution of Pharma Depends on Data Integration and Application
New business models must be adopted to leverage the massive amounts of data generated across the pharma/healthcare continuum.


Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?

New Drug News

Regulatory Approval Brings siRNA into the Rare Disease Toolbox
David Alvaro, Ph.D., Scientific Editorial Director, Nice Insight

Regulatory Spotlight

FDA Delays Enforcement of Serialization Mandate

KshitiJ (TJ) Ladage, Market Research Manager, Nice Insight